Jefferies analyst David Windley maintained a Buy rating on West Pharmaceutical Services (WST – Research Report) today and set a price target of $393.00. The company’s shares closed yesterday at
Jefferies analyst David Windley maintained a Buy rating on West Pharmaceutical Services (WST – Research Report) today and set a price target of $393.00. The company’s shares closed yesterday at
West Pharmaceutical Services (NYSE: WST) has declared, under its dividend policy, a quarterly cash dividend in the amount of $0.21 per common share. That signifies an annualized amount of $0.84
In a report released today, Michael Ryskin from Bank of America Securities maintained a Buy rating on West Pharmaceutical Services (WST – Research Report). The company’s shares opened today at
Jefferies analyst David Windley reiterated a Buy rating on West Pharmaceutical Services (WST – Research Report) today and set a price target of $393.00. The company’s shares closed yesterday at
West Pharmaceutical (WST) is up 21.8%, or $62.49 to $348.93. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks